Navigation Links
Novo Nordisk Makes its Debut in FORTUNE's '100 Best Companies to Work For'
Date:1/22/2009

PRINCETON, N.J., Jan. 22 /PRNewswire-FirstCall/ -- Novo Nordisk, a global healthcare company focusing on diabetes care, has been named in FORTUNE's 2009 "100 Best Companies to Work For" awards issue. This is the first year that Novo Nordisk has received this prestigious award -- one of the most influential business scorecards in the nation. FORTUNE's "100 Best Companies to Work For" are historically good performers in the marketplace for not only current and prospective employees, but shareholders as well.

"It is an honor to be named one of the '100 Best Companies to Work For,'" said Jerzy Gruhn, president of Novo Nordisk Inc. "Our company reflects the passion our employees bring to our vision of defeating diabetes and helping people with unmet medical needs. That is what makes our company a 'Best Company to Work For.'"

Developed by FORTUNE and Great Places to Work Institute(R), the award is based on employee surveys as well as an audit of the company. The survey rates employees' opinions about how well their company promotes a positive work environment through benefit packages and professional development opportunities. It also surveys attitudes about management credibility, job satisfaction and even camaraderie. Another portion of the scoring is based on the company's responses to the Institute's Culture Audit, which includes detailed questions about demographic makeup, pay and benefit programs, as well as a series of open-ended questions about a company's management philosophy, internal communications approach, opportunities for promotion, compensation practices and diversity programs.

"To be recognized as one of the best companies to work for in the U.S. is a testament to Novo Nordisk's ability to build and maintain an environment where employees can thrive," said Jeff Frazier, Vice President of Human Resources.

"Our dedication to our employees is part of our so
'/>"/>

SOURCE Novo Nordisk Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Novo Nordisk Changing Diabetes(R) Bus Boogies into San Francisco on World Tour to Beat Diabetes
2. FDA Approves NOVO NORDISKs NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
3. Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
4. Novo Nordisk Files Annual Report with the SEC
5. Novo Nordisk Increased Net Profit by 32% in 2007
6. Novo Nordisk Settles With Pfizer On Patent Infringement Suit
7. Novo Nordisk Ranks Supersector Leader in the 2007 Dow Jones Sustainability Indexes
8. Novo Nordisk Appoints New Leader of North American Business
9. No Germs, No Fires, No Mess: New Product Makes Good Health Easy and Natural
10. Access Family Services, Inc. Makes the List for the Second Year in a Row! Access Family Services 2008 Ranks No. 2851 on the Inc. 5000 With Three-Year Sales Growth of 128%
11. Meridian Makes CES Good For Your Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... -- Vasectomy was associated with a small increased risk ... or lethal prostate cancer according to a new study ... found that the association remained even among men who ... lethal cancer cannot be explained by diagnostic bias. It ... to look at the link between vasectomy and prostate ...
(Date:7/9/2014)... captures heretofore hidden ways that cells are regulated, scientists ... breast cancer cells more likely to metastasize. , What,s ... part by blocking two other proteins that are normally ... disease processes could have unexpected ties. , The ... Nature , points to the possibility of new ...
(Date:7/9/2014)... Researchers have found that fecal transplantation is effective ... immunocompromised patients. This is the result of a study ... Center for Women,s Gastrointestinal Medicine at The Women,s Medicine ... online in advance of print in the American ... or C. diff , has increased to epidemic ...
(Date:7/9/2014)... By looking at ... structure and function, personality, life experiences and genetics, researchers can ... binge drinking within the next two years. Impulsivity, hopelessness, sensation-seeking ... events and a family history of drug use contribute to ... child had had a single drink at age 14 was ...
(Date:7/9/2014)... for more than watching World Cup highlights, Brian Williams ... landing in unfortunate positions on railings. A University of ... Online Journal shows that YouTube also allows researchers, ... public on topics of skin cancer and prevention. , ... the future of how we communicate around the world," ...
Breaking Medicine News(10 mins):Health News:Vasectomy may increase risk of aggressive prostate cancer 2Health News:Protein pushes breast cancer cells to metastasize 2Health News:Protein pushes breast cancer cells to metastasize 3Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:What drives a child to abuse alcohol? 2Health News:Study of dermatology on YouTube shows new ways science reaches public 2
... Broad Institute of Harvard and MIT have received a ... ways to encourage the human body to replenish the ... by the Juvenile Diabetes Research Foundation (JDRF), the $3M ... fields, genome biology and chemical biology, to address a ...
... NASHUA, N.H., July 21 iCAD, Inc. (Nasdaq:,ICAD), ... announced the completion of its previously announced,agreement to ... medical technology company based in White Plains, NY. ... million in cash and,1,086,957 shares of iCAD common ...
... July 21 Fidelity National,Financial, Inc. (NYSE: ... insurance, claims management services and information services,today announced ... Mexico,Fidelity National Title de Mexico S.A. de C.V. ... been appointed Vice President and General,Manager and Gerardo ...
... July 21 iNutrition, Inc, (http://www.inutrition.com ) ... of Natural Nutrition, Inc, (OTC,Bulletin Board: NTNI) ... an,agreement with actor John O,Hurley ("Seinfeld," "Dancing ... endorser and spokesman for the Companies in,their ...
... melatonin strip ... BOCA RATON, Fla., July 21 TransMedia Group said it ... Sleep, all-natural,sleep aid for people who can,t wait for pills to ... asleep fast and safely. MedGen Inc.,the makers of Snorenz, which has ...
... university aligns with National League of Nursing competencies; helps address ... ... Minneapolis, MN (PRWEB) July 20, 2008 -- Capella University ... has announced a new PhD in Education specialization in Nursing ...
Cached Medicine News:Health News:Broad Institute earns grant to support pathbreaking diabetes study 2Health News:Broad Institute earns grant to support pathbreaking diabetes study 3Health News:iCAD Completes Acquisition of CAD Sciences 2Health News:Fidelity National Financial, Inc. Announces Opening of Fidelity National Title de Mexico S.A. de C.V. 2Health News:Fidelity National Financial, Inc. Announces Opening of Fidelity National Title de Mexico S.A. de C.V. 3Health News:iNutrition Signs John O'Hurley to Launch New Internet Video Campaign 2Health News:Sweet Dreams, Sweet Breath: MedGen Inc. Retains TransMedia Group to Send Media a Wake-Up Call About an All-Natural, Quick New Way to Slumber Land 2Health News:Capella University Launches Online PhD Specialization in Nursing Education 2Health News:Capella University Launches Online PhD Specialization in Nursing Education 3
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... Limited (the "Company") and Celtic Therapeutics Holdings LP ("Celtic ... clinical trial of SG2000 in ovarian cancer.  The trial ... of the USA, and is now actively recruiting patients ... will evaluate the overall response rate of SG2000 in ...
... (NYSE: AZN ) today announced that ... extended the time to complete its review of ... (Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO) (Logo: ... Prescription Drug User Fee Act (PDUFA) date from ...
Cached Medicine Technology:Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer 2Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer 3U.S. Food and Drug Administration Extends Review Timeline for BRILINTA (Ticagrelor) New Drug Application 2
... a two-level control compatible with popular ... Strips and Roche Micral test strips. ... turbidimetric immunoassays using AU Series, Bayer ... Cobas, Diasorin SPQ Test System, Dimension, ...
... the performance of Abuscreen ONLINE, AxSYM, EMIT, ... methods. This control meets current revised guidelines ... Health Services Administration (SAMSHA). Level 1 is ... analytes below screening cut-off levels (negative threshold ...
... 190 spectrophotometer is ideal for most life ... solutions, our patented* PathCheck sensor technology senses ... microplate well, and normalizes the absorbance value ... is within 5% of the value obtained ...
... This control is intended as a ... testing methods. A new feature is ... CRP. It is compatible with most ... ACS:180, Access, Dimension, Elecsys, Stratus and ...
Medicine Products: